Reglagene

Reglagene's mission is to discover and develop low-cost and noninvasive therapeutic solutions that regain control of genes exploited by cancer to keep patients responsive to treatment. Reglagene's technology is the product of 20 years of meticulous research from the labs of Professor Laurence Hurley at the University of Arizona. Professor Hurley discovered that unusual DNA structures called "quadruplexes," found in many genes exploited by cancer and other diseases, are actually master controllers of gene expression.